Immunoprecise Cost of Revenue Trend from 2010 to 2022

Immunoprecise Antibodies Cost of Revenue is increasing over the years with slightly volatile fluctuation. Ongoing Cost of Revenue is projected to grow to about 7.3 M this year. From 2010 to 2022 Immunoprecise Antibodies Cost of Revenue quarterly data regression line had arithmetic mean of 5,980,781 and slope of  125,677. Immunoprecise Antibodies Cost of Revenue is projected to increase significantly based on the last few years of reporting. The past year's Cost of Revenue was at 7.33 Million. The current year Interest Expense is expected to grow to about 596.1 K, whereas Consolidated Income is forecasted to decline to (9.1 M).
  
Refresh
Check Immunoprecise Antibodies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immunoprecise main balance sheet or income statement drivers, such as Cost of Revenue of 7.3 M, Gross Profit of 11.8 M or Interest Expense of 596.1 K, as well as many exotic indicators such as Asset Turnover of 0.36, Book Value per Share of 3.25 or Current Ratio of 9.98. Immunoprecise financial statements analysis is a perfect complement when working with Immunoprecise Antibodies Valuation or Volatility modules. It can also supplement various Immunoprecise Antibodies Technical models. Check out Risk vs Return Analysis.

Immunoprecise Cost of Revenue Breakdown

Showing smoothed Cost of Revenue of Immunoprecise Antibodies with missing and latest data points interpolated. Cost of Revenue is found on Immunoprecise Antibodies income statement and represents the costs associated with goods and services Immunoprecise Antibodies provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. The aggregate cost of goods produced and sold and services rendered during the reporting period.Immunoprecise Antibodies' Cost of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immunoprecise Antibodies' overall financial position and show how it may be relating to other accounts over time.
Cost of Revenue10 Years Trend
Increasing
Slightly volatile
 Cost of Revenue 
Share
      Timeline 

Immunoprecise Cost of Revenue Regression Statistics

Arithmetic Mean 5,980,781
Geometric Mean 5,952,040
Coefficient Of Variation 10.70
Mean Deviation 483,435
Median 5,631,634
Standard Deviation 639,959
Range 1,705,717
R-Value 0.76
R-Squared 0.58
Significance 0.002323
Slope 125,677

Immunoprecise Cost of Revenue History

2019M
20206.4 M
20217.3 M
20227.3 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Immunoprecise Antibodies without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Probability Of Bankruptcy Now

   

Probability Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immunoprecise Antibodies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Risk vs Return Analysis. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Tools for Immunoprecise Stock

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go